Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
Key objectives of this clinical study are to:
- Determine how well intramuscular (IM) olanzapine depot works compared to placebo
- Evaluate the safety and tolerability of IM olanzapine depot compared to placebo
- Evaluate different doses of IM olanzapine depot compared to placebo to identify the best
dose(s).